Wolverine Trading, LLC Grifols Sa Put Options Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$6.27 - $7.7 $122,264 - $150,150	-19,500 Reduced 51.72%	18,200 $114,000
Q1 2024 May 15, 2024	BUY	$5.47 - $11.38 $206,219 - $429,026	37,700 New	37,700 $251,000
Q3 2023 Nov 15, 2023	BUY	$8.91 - $10.91 $70,389 - $86,189	7,900 Added 46.75%	24,800 $226,000
Q2 2023 Aug 23, 2023	BUY	$7.14 - $9.29 $120,666 - $157,001	16,900 New	16,900 $154,000
Q4 2022 Feb 14, 2023	SELL	$5.96 - $8.53 $12,516 - $17,913	-2,100 Reduced 15.44%	11,500 $98,000
Q3 2022 Nov 14, 2022	BUY	$5.95 - $14.3 $80,920 - $194,480	13,600 New	13,600 $81,000
Q1 2021 May 14, 2021	SELL	$15.15 - $19.78 $256,035 - $334,282	-16,900 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$16.86 - $19.67 $116,334 - $135,723	6,900 Added 69.0%	16,900 $313,000
Q3 2020 Nov 13, 2020	BUY	$15.4 - $20.16 $154,000 - $201,600	10,000 New	10,000 $168,000

167

140M

268K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $4.75B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.